Retroviral transfer and expression of human MDR-1 in a murine haemopoietic stem cell line does not alter factor dependence, growth or differentiation characteristics.

In view of the recent report of a myeloproliferative syndrome in mice that had received an MDR-1-transduced haemopoietic graft, we have investigated the potential effects of MDR-1 expression on primitive haemopoietic cell growth and differentiation. Retroviral gene transfer was used to achieve exogenous expression of either MDR-1 or truncated nerve growth factor receptor (tNGFR) in the multipotent murine haemopoietic progenitor cell line, FDCP-mix. Following gene transfer, clonal lines were derived and FACS analysis confirmed appropriate expression of each transgene. MDR-1 (but not tNGFR) expression was associated with verapamil-sensitive rhodamine efflux and resistance to killing by etoposide. When growth factor responsiveness, proliferative capacity and differentiation capacity were examined, MDR-1 expressing FDCP-mix cells exhibited a normal phenotype and mimicked the response of tNGFR-expressing or untransduced FDCP-mix cells. Thus, in the model system we have used, MDR-1 does not perturb haemopoietic cell growth and development and our data do not support a myeloproliferative role for MDR-1.

Reproductive violence screening in primary care: perspectives and experiences of patients and battered women.

OBJECTIVE: To ascertain how women want health care providers to address domestic violence during primary care visits. METHODS: 80 female patients seen at an urban family practice and 91 women from four urban domestic violence programs (64 outreach clients and 27 shelter residents) were asked about screening for domestic violence between February and May 1996. Domestic violence was defined as physical and/or sexual violence by a male intimate partner. RESULTS: 7.7% of the 40 nonabused women patients reported being previously asked about abuse compared with 25.0% of the 40 abused women patients, 44.4% of outreach clients, and 37.0% of shelter residents. No patients had used community domestic violence services. Most women agreed that health care providers should screen female patients for abuse. Nonabused women typically suggested general screening questions, compared with the more specific screening questions suggested by abused women. Suggested provider interventions reflected recommendations by medical organizations. Fear of losing control and personal feelings (e.g., shame) inhibited some women from discussing abuse with physicians. CONCLUSIONS: Both nonabused and abused women agreed that health care providers should screen female patients for domestic violence. Integrating medical recommendations with practices acceptable to patients is an important step in developing feasible protocols that can be maintained in routine practice.

CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors.

The AC133 antigen is a novel antigen selectively expressed on a subset of CD34+ cells in human fetal liver, bone marrow, and blood as demonstrated by flow cytometric analyses. In this study, we have further assessed the expression of AC133 on CD34+ cells in hemopoietic samples and found that there was a highly significant difference between normal bone marrow and cord blood versus aphereses (p <0.0001) but not between bone marrow and cord blood. Most of the clonogenic cells (67%) were contained in the CD34+AC133+ fraction. Compared with cultures of the CD34+AC133- cells, generation of progenitor cells in long-term culture on bone marrow stroma was consistently 10- to 100-fold higher in cultures initiated with CD34+AC133+ cells and was maintained for the 8-10 weeks of culture. Only the CD34+AC133+ cells were capable of repopulating NOD/SCID mice. Human cells were detectable as early as day 20, with increased levels (67%) apparent 40 days post-transplantation. Five thousand CD34+AC133+ cells engrafted about 20% of the mice, while no engraftment was observed in animals transplanted with up to 1.2 x 10(5) CD34+AC133- cells. The CD34+AC133+ population was also enriched (seven-fold) in dendritic cell precursors, and the dendritic cells generated were functionally active in a mixed lymphocyte reaction assay. AC133+ cells should be useful in the study of cellular and molecular mechanisms regulating primitive hemopoietic cells.